Intra-tumoral Mitazalimab (CD40 Antibody) With Irreversible Electroporation (IRE) in Locally Advanced Pancreas Cancer
Condition(s):Pancreatic CancerLast Updated:January 16, 2024Not yet recruiting
Hide Studies Not Open or Pending
Condition(s):Pancreatic CancerLast Updated:January 16, 2024Not yet recruiting
Condition(s):MEASLES DISEASELast Updated:May 31, 2017Unknown status
Condition(s):Breast Cancer; HER2+ Breast CancerLast Updated:March 22, 2024Active, not recruiting
Condition(s):Plaque-type PsoriasisLast Updated:March 18, 2015Completed
Condition(s):Non Small Cell Lung Cancer; Influenza VaccineLast Updated:April 21, 2020Unknown status
Condition(s):Ovarian Cancer; Fallopian Tube Cancer; Peritoneal CancerLast Updated:May 6, 2023Completed
Condition(s):Breast Cancer MetastaticLast Updated:March 7, 2024Completed
Condition(s):D Vitamin Deficiency PatientsLast Updated:December 23, 2015Terminated
Condition(s):Effect of DrugLast Updated:February 21, 2023Recruiting
Condition(s):Diabetes Mellitus, Type 1Last Updated:January 17, 2018Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.